Fairmount Funds Management LLC 13D and 13G filings for Kiniksa Pharmaceuticals, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 3:46 pm Purchase | 2023-12-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | Fairmount Funds Management LLC | 2,883,221 8.100% | 740,169 (+34.54%) | Filing |
| 2023-08-10 4:15 pm Purchase | 2023-08-02 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | Fairmount Funds Management LLC | 2,143,052 6.100% | 2,143,052 (New Position) | Filing |